2025-08-15T16:02:27-05:00 2024-12-31 390859910 BAKER TILLY ADVISORY GROUP LP 101 SECOND STREET SUITE 900 SAN FRANCISCO CA 94105 990 2024-01-01 273868699 AMERICAN GLAUCOMA SOCIETY FOUNDATION AMER 4155618587 655 BEACH STREET SAN FRANCISCO CA 94109 GREGORY L SKUTA MD EXECUTIVE VICE PRESIDENT 4155618587 2025-08-13 1 0 MICHAEL LUMSDEN P01262236 4159561500 2025-08-13 2024 2025-03-06 01:10:19Z STEVEN J GEDDE MD 655 BEACH STREET SAN FRANCISCO CA 94109 397094 0 X WWW.AMERICANGLAUCOMASOCIETY.NET X 2010 CA TO SUPPORT GLAUCOMA RESEARCH AND EDUCATION, AND TO PROMOTE EXCELLENCE IN THE CARE OF PATIENTS WITH GLAUCOMA. 21 21 0 28 0 0 278423 394444 0 0 1790 2560 0 0 280213 397004 200000 275000 0 0 0 0 0 0 0 36774 25647 236774 300647 43439 96357 381521 490495 5675 9698 375846 480797 X TO SUPPORT GLAUCOMA RESEARCH AND EDUCATION, AND TO PROMOTE EXCELLENCE IN THE CARE OF PATIENTS WITH GLAUCOMA. 0 0 150000 150000 0 AGSF PROVIDED AGS $150,000 IN FUNDING TO SUPPORT RESEARCH AND EDUCATION PROGRAMS SPONSORED BY AGS AIMED AT MAKING A SIGNIFICANT IMPACT IN THE FIGHT TO PREVENT BLINDNESS AND VISUAL IMPAIRMENT. EXAMPLES INCLUDE: (I) GRANTS TO YOUNG CLINICIAN SCIENTISTS TO ENCOURAGE THE DEVELOPMENT OF YOUNG CLINICIAN SCIENTISTS IN GLAUCOMA BY PROVIDING FUNDING FOR RESEARCH PROJECTS WITHIN THE FIRST 5 YEARS AFTER GRADUATION, AND (II) GRANTS TO MID-CAREER PHYSICIAN SCIENTISTS TO ALLOW MID-CAREER (BETWEEN 5 AND 20 YEARS AFTER FELLOWSHIP) TO INITIATE NEW RESEARCH OR CONTINUE ONGOING RESEARCH. 70000 70000 0 AGSF PROVIDED AGS $70,000 IN FUNDING TO SUPPORT THE GEORGE L. SPAETH MD ENDOWED INTERNATIONAL GLAUCOMA FELLOWSHIP FUND, WHICH WAS ESTABLISHED TO ADVANCE GLAUCOMA CARE TO THE BENEFIT OF HUMANKIND IN PERPETUITY. 50000 50000 0 AGSF PROVIDED AGS $50,000 IN FUNDING TO SUPPORT AGS CARES WHICH IS A PUBLIC SERVICE PROGRAM SUPPORTED BY THE AGS FOUNDATION THAT IS DEDICATED TO PROVIDING SURGICAL GLAUCOMA CARE AT NO COST TO UNINSURED OR UNDER-SERVED PATIENTS WHO QUALIFY FOR SUCH CARE. THE GLAUCOMA CARE IS PROVIDED BY MEMBERS OF A NATIONAL NETWORK OF VOLUNTEERS COMPRISING GLAUCOMA SURGEONS WHO ARE AGS ACTIVE OR PROVISIONAL MEMBERS. 5000 5000 0 AGSF PROVIDED SUPPORT TO OUTSIDE ORGANIZATIONS (THE FOUNDATION OF THE AMERICAN ACADEMY OF OPHTHALMOLOGY) WHOSE MISSION SUPPORTS EYE HEALTH. 5000 5000 0 275000 1 1 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 2 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 X 21 21 0 1 0 0 1 1 0 1 1 0 0 1 1 1 1 1 1 0 0 0 AL AK AR CA CO CT DC FL GA HI IL KS KY ME MD MA MI MN MS NV NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA WA WV WI X WAJHMA ABOUD 4155618587 655 BEACH STREET SAN FRANCISCO CA 94109 X LEON W HERNDON JR MD PRES THRU 3/2024 / PAST PRESIDENT 1.00 1.00 X X 0 0 0 CARLA J SIEGFRIED MD VP THRU 3/2024 / PRES START 3/2024 1.00 1.00 X X 0 0 0 STEVEN J GEDDE MD VICE PRESIDENT START 3/2024 1.00 1.00 X X 0 0 0 DAVID G GODFREY MD TREASURER 1.00 1.00 X X 0 0 0 JOANN A GIACONI MD SECRETARY THRU 3/2024 1.00 1.00 X X 0 0 0 JOSHUA D STEIN MD MS SECRETARY START 3/2024 1.00 1.00 X X 0 0 0 LAMA A AL-ASWAD MD MPH MEMBER-AT-LARGE THRU 3/2024 1.00 1.00 X 0 0 0 CATHY G COHEN MEMBER-AT-LARGE 1.00 0.00 X 0 0 0 ANNE L COLEMAN MD MEMBER-AT-LARGE 1.00 0.00 X 0 0 0 GEOFFREY T EMERICK MD PATIENT CARE COMMITTEE CHAIR 1.00 1.00 X 0 0 0 RONALD L FELLMAN MD PAST PRESIDENT THRU 3/2024 1.00 1.00 X 0 0 0 ANN CAROLINE FISHER MD DEI COMMITTEE CHAIR 1.00 1.00 X 0 0 0 CHRISTOPHER A GIRKIN MD MSPH PAST PRESIDENT 1.00 1.00 X 0 0 0 YING HAN MD PHD RESEARCH COMMITTEE CHAIR 1.00 1.00 X 0 0 0 SHIVANI S KAMAT MD JR. MEMBER-AT-LARGE START 3/2024 1.00 1.00 X 0 0 0 MICHELE C LIM MD PROGRAM COMMITTEE CHAIR THRU 3/2024 1.00 1.00 X 0 0 0 STEVEN L MANSBERGER MD MPH LEAD AMBASSADOR START 3/2024 1.00 1.00 X 0 0 0 FELIPE A MEDEIROS MD PHD BYLAWS/STRAT PLANNING COMM CHAIR 1.00 1.00 X 0 0 0 KELLY W MUIR MD EDUCATION AND COMMUNICATION CHAIR 1.00 1.00 X 0 0 0 PETER A NETLAND MD PHD MEMBER-AT-LARGE 1.00 0.00 X 0 0 0 KOUROS NOURI-MAHDAVI MD MSC PROGRAM COMMITTEE CHAIR START 3/2024 1.00 1.00 X 0 0 0 ROMA PATEL MD MEMBER-AT-LARGE 1.00 1.00 X 0 0 0 DOUGLAS J RHEE MD MEMBER-AT-LARGE THRU 3/2024 1.00 1.00 X 0 0 0 OLUWATOSIN U SMITH MD MEMBER-AT-LARGE START 3/2024 1.00 1.00 X 0 0 0 SAMUEL SOLISH MD COUNCILOR TO AAO 1.00 1.00 X 0 0 0 ANGELA V TURALBA MD MMS MEMBER-AT-LARGE 1.00 1.00 X 0 0 0 THASARAT S VAJARANANT MD LEAD AMBASSADOR THRU 3/2024 1.00 1.00 X 0 0 0 KATEKI VINOD MD MEMBER-AT-LARGE THRU 3/2024 1.00 1.00 X 0 0 0 0 0 0 0 0 0 0 0 394444 394444 2443 2443 207 90 117 117 117 397004 0 0 2560 275000 275000 14774 14774 4300 4300 5077 5077 1243 1243 253 253 300647 275000 25647 0 233131 218302 30000 110000 87633 101813 30757 60380 381521 490495 5675 9698 5675 9698 X 277796 300322 98050 180475 375846 480797 381521 490495 96357 8594 0 X 0 1 X 1 0 X 253549 358752 156026 278423 394444 1441194 253549 358752 156026 278423 394444 1441194 515558 925636 9821 1234 1253 1902 2443 16653 1457847 0.63490 0.59770 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 DUE FROM RELATED ORGANIZATION 60380 60380 X PART X, LINE 2: THE INTERNAL REVENUE SERVICE HAS DETERMINED THAT THE AGS AND AGSF ARE EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) IN THE INTERNAL REVENUE CODE. HOWEVER, INCOME FROM ACTIVITIES NOT RELATED TO THEIR TAX-EXEMPT PURPOSE MAY BE SUBJECT TO TAXATION AS UNRELATED BUSINESS INCOME. THERE WAS NO UNRELATED BUSINESS INCOME SUBJECT TO TAXATION FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023. 1 AMERICAN GLAUCOMA SOCIETY INC 655 BEACH STREET SAN FRANCISCO CA 94109 222765077 501(C)(3) 270000 0 RESEARCH AND ORGANIZATIONAL SUPPORT 1 0 PART I, LINE 2: THE ORGANIZATION'S BOARD IS INTIMATELY INVOLVED WITH THE WORK OF THE GRANT RECIPIENT, AMERICAN GLAUCOMA SOCIETY, INC. (AGS). THE BOARD OF DIRECTORS OF AGS IS COMPRISED SOLELY OF MEMBERS WHO ALSO SIT ON THE BOARD OF AGSF; THUS, GRANTS TO AGS ARE MONITORED VIA OVERLAPPING GOVERNANCE. FORM 990, PART VI, SECTION A, LINE 3 AGSF HAS A MANAGEMENT CONTRACT WITH SAN FRANCISCO ASSOCIATION MANAGEMENT SERVICES (SF-AMS). UNDER THE ANNUAL CONTRACT, ALL PERSONNEL DECISIONS AND FINANCIAL OPERATIONS ARE THE RESPONSIBILITY OF SF-AMS. FORM 990, PART VI, SECTION A, LINE 6 THE ORGANIZATION DOES NOT HAVE "MEMBERS" BY DEFINITION OF THE BYLAWS. HOWEVER, THE FORM 990 INSTRUCTIONS DEFINE A "MEMBER" AS ANY PERSON (INCLUDING A CORPORATION OR OTHER LEGAL ENTITY) WHO, PURSUANT TO A PROVISION IN THE ORGANIZATION'S GOVERNING DOCUMENTS, HAS THE RIGHT TO PARTICIPATE IN THE ORGANIZATION'S GOVERNANCE, INCLUDING ELECTING MEMBERS OF THE GOVERNING BODY. ACCORDINGLY, AGSF HAS ONE SOLE MEMBER: AMERICAN GLAUCOMA SOCIETY, INC. FORM 990, PART VI, SECTION A, LINE 7A ALL OF THE DIRECTORS OF THE AMERICAN GLAUCOMA SOCIETY, INC. (AGS), A CALIFORNIA NONPROFIT CORPORATION EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE, SHALL AUTOMATICALLY BE DIRECTORS OF THIS CORPORATION, BUT ONLY FOR SO LONG AS THEY REMAIN DIRECTORS OF AGS. THE DIRECTORS OF AGS MAY ALSO APPOINT UP TO FIVE ADDITIONAL DIRECTORS TO THE BOARD OF AGSF. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS PREPARED BY AN OUTSIDE TAX PROFESSIONAL. THE FORM IS THEN REVIEWED BY THE FINANCE AND ACCOUNTING STAFF OF THE ORGANIZATION'S MANAGEMENT COMPANY, WITH QUESTIONS REFERRED TO THE OUTSIDE TAX PROFESSIONAL. AFTER A FULL REVIEW (WITH MODIFICATIONS WHERE NECESSARY), THE FINAL VERSION OF THE FORM 990 IS PROVIDED TO ALL MEMBERS OF THE ORGANIZATION'S VOTING GOVERNING BODY PRIOR TO FILING WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C IT IS THE POLICY OF THE BOARD OF DIRECTORS OF AGSF THAT ITS DIRECTORS DISCLOSE AND, DEPENDING ON THE CIRCUMSTANCES, AVOID ANY AND ALL POSSIBLE CONFLICTS OF INTEREST. A DIRECTOR HAS A CONFLICT OF INTEREST WHEN A PERSON OR A MEMBER OF HIS OR HER FAMILY HAS A RELATIONSHIP WITH, OR AN INTEREST IN, AN ENTITY THAT DOES BUSINESS WITH AGSF OR IS A COMPETITOR OF AGSF. THIS POLICY IS IMPLEMENTED AND ENFORCED SO AS TO PREVENT THE JUDGMENT OF THE BOARD FROM BEING INFLUENCED BY AN ECONOMIC RELATIONSHIP IN WHICH A DIRECTOR OF HIS/HER FAMILY IS PERSONALLY INVOLVED. DIRECTORS SATISFY TWO OBLIGATIONS IN REGARDS TO THIS CONFLICT OF INTEREST POLICY: (1) ASCERTAINING AND DISCLOSING THEIR OWN FAMILY CONFLICTS, AND (2) DETERMINING WHETHER ANOTHER INVOLVED PERSON SHOULD PARTICIPATE IN DELIBERATIONS AND/OR VOTING ON AN ISSUE WITH RESPECT TO WHICH HE/SHE HAS A CONFLICT. A DIRECTOR WILL DISCLOSE ANY CONFLICT AT BOARD MEETINGS AND RECUSE THEMSELVES IF SUCH CONFLICT EXISTS. TO ACCOMPLISH AND FULFILL THIS POLICY, ALL DIRECTORS ANNUALLY SUBMIT A DISCLOSURE STATEMENT, AND ARE RESPONSIBLE FOR UPDATING THE STATEMENT IF CHANGES OCCUR DURING THE YEAR. FORM 990, PART VI, SECTION C, LINE 19 AGSF MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. AMERICAN GLAUCOMA SOCIETY INC 655 BEACH STREET SAN FRANCISCO CA 94109 222765077 TO PROMOTE THE IMPROVEMENT AND EXCHANGE OF GLAUCOMA-RELATED INFORMATION CA 501(C)(3) LINE 10 N/A 1 0 1 0 1 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 AMERICAN GLAUCOMA SOCIETY INC B 270000 BOOK VALUE AMERICAN GLAUCOMA SOCIETY INC D 60380 BOOK VALUE